Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Interplay between Metabolites and the Epigenome in Regulating Embryonic and Adult Stem Cell Potency and Maintenance.

Harvey A, Caretti G, Moresi V, Renzini A, Adamo S.

Stem Cell Reports. 2019 Oct 8;13(4):573-589. doi: 10.1016/j.stemcr.2019.09.003. Review.

2.

Metabolic Control of Stemness and Differentiation.

Moresi V, Sotiropoulos A, Caretti G, Harvey A.

Stem Cells Int. 2019 Jun 12;2019:6865956. doi: 10.1155/2019/6865956. eCollection 2019. No abstract available.

3.

SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.

Fenizia C, Bottino C, Corbetta S, Fittipaldi R, Floris P, Gaudenzi G, Carra S, Cotelli F, Vitale G, Caretti G.

Nucleic Acids Res. 2019 Feb 20;47(3):1278-1293. doi: 10.1093/nar/gky1221.

4.

The Trithorax protein Ash1L promotes myoblast fusion by activating Cdon expression.

Castiglioni I, Caccia R, Garcia-Manteiga JM, Ferri G, Caretti G, Molineris I, Nishioka K, Gabellini D.

Nat Commun. 2018 Nov 28;9(1):5026. doi: 10.1038/s41467-018-07313-8.

5.

Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.

Segatto M, Fittipaldi R, Pin F, Sartori R, Dae Ko K, Zare H, Fenizia C, Zanchettin G, Pierobon ES, Hatakeyama S, Sperti C, Merigliano S, Sandri M, Filippakopoulos P, Costelli P, Sartorelli V, Caretti G.

Nat Commun. 2017 Nov 22;8(1):1707. doi: 10.1038/s41467-017-01645-7.

6.

Vitamin D and VDR in cancer cachexia and muscle regeneration.

Camperi A, Pin F, Costamagna D, Penna F, Menduina ML, Aversa Z, Zimmers T, Verzaro R, Fittipaldi R, Caretti G, Baccino FM, Muscaritoli M, Costelli P.

Oncotarget. 2017 Mar 28;8(13):21778-21793. doi: 10.18632/oncotarget.15583.

7.

Epigenetic Regulation Shapes the Stem Cells State.

Caretti G, Berghella L, Juan A, Latella L, Ryall J.

Stem Cells Int. 2016;2016:8143407. doi: 10.1155/2016/8143407. Epub 2016 Jan 24. No abstract available.

8.

A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth.

Peserico A, Germani A, Sanese P, Barbosa AJ, Di Virgilio V, Fittipaldi R, Fabini E, Bertucci C, Varchi G, Moyer MP, Caretti G, Del Rio A, Simone C.

J Cell Physiol. 2015 Oct;230(10):2447-2460. doi: 10.1002/jcp.24975.

9.

The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.

Proserpio V, Fittipaldi R, Ryall JG, Sartorelli V, Caretti G.

Genes Dev. 2013 Jun 1;27(11):1299-312. doi: 10.1101/gad.217240.113.

10.

Tackling skeletal muscle cells epigenome in the next-generation sequencing era.

Fittipaldi R, Caretti G.

Comp Funct Genomics. 2012;2012:979168. doi: 10.1155/2012/979168. Epub 2012 Jun 3.

11.

In vitro profiling of epigenetic modifications underlying heavy metal toxicity of tungsten-alloy and its components.

Verma R, Xu X, Jaiswal MK, Olsen C, Mears D, Caretti G, Galdzicki Z.

Toxicol Appl Pharmacol. 2011 Jun 15;253(3):178-87. doi: 10.1016/j.taap.2011.04.002. Epub 2011 Apr 14.

PMID:
21513724
12.

Phosphoryl-EZH-ion.

Caretti G, Palacios D, Sartorelli V, Puri PL.

Cell Stem Cell. 2011 Mar 4;8(3):262-5. doi: 10.1016/j.stem.2011.02.012.

13.

TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration.

Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V, Marquez VE, Valente S, Mai A, Forcales SV, Sartorelli V, Puri PL.

Cell Stem Cell. 2010 Oct 8;7(4):455-69. doi: 10.1016/j.stem.2010.08.013.

14.

Posttranslational regulation of NF-YA modulates NF-Y transcriptional activity.

Manni I, Caretti G, Artuso S, Gurtner A, Emiliozzi V, Sacchi A, Mantovani R, Piaggio G.

Mol Biol Cell. 2008 Dec;19(12):5203-13. doi: 10.1091/mbc.E08-03-0295. Epub 2008 Sep 24.

15.

MyoD acetylation influences temporal patterns of skeletal muscle gene expression.

Di Padova M, Caretti G, Zhao P, Hoffman EP, Sartorelli V.

J Biol Chem. 2007 Dec 28;282(52):37650-9. Epub 2007 Oct 27.

16.

p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation.

Jensen ED, Niu L, Caretti G, Nicol SM, Teplyuk N, Stein GS, Sartorelli V, van Wijnen AJ, Fuller-Pace FV, Westendorf JJ.

J Cell Biochem. 2008 Apr 1;103(5):1438-51.

PMID:
17960593
17.

The DEAD-box p68/p72 proteins and the noncoding RNA steroid receptor activator SRA: eclectic regulators of disparate biological functions.

Caretti G, Lei EP, Sartorelli V.

Cell Cycle. 2007 May 15;6(10):1172-6. Epub 2007 May 3. Review.

PMID:
17495528
18.

The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation.

Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V, Fuller-Pace FV, Hoffman EP, Tapscott SJ, Sartorelli V.

Dev Cell. 2006 Oct;11(4):547-60.

19.

The Pole3 bidirectional unit is regulated by MYC and E2Fs.

Bolognese F, Forni C, Caretti G, Frontini M, Minuzzo M, Mantovani R.

Gene. 2006 Jan 17;366(1):109-16. Epub 2006 Jan 3.

PMID:
16403426
20.

Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway.

Zhao P, Caretti G, Mitchell S, McKeehan WL, Boskey AL, Pachman LM, Sartorelli V, Hoffman EP.

J Biol Chem. 2006 Jan 6;281(1):429-38. Epub 2005 Nov 2.

21.

Mechanisms underlying the transcriptional regulation of skeletal myogenesis.

Sartorelli V, Caretti G.

Curr Opin Genet Dev. 2005 Oct;15(5):528-35. Review.

22.

The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.

Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V.

Genes Dev. 2004 Nov 1;18(21):2627-38. Erratum in: Genes Dev. 2005 Mar 15;19(6):768.

23.

Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin.

Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E, Minetti G, Zhao P, Hoffman EP, Puri PL, Sartorelli V.

Dev Cell. 2004 May;6(5):673-84.

24.

Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2.

Tessari MA, Gostissa M, Altamura S, Sgarra R, Rustighi A, Salvagno C, Caretti G, Imbriano C, Mantovani R, Del Sal G, Giancotti V, Manfioletti G.

Mol Cell Biol. 2003 Dec;23(24):9104-16.

25.

Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters.

Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R.

J Biol Chem. 2003 Aug 15;278(33):30435-40. Epub 2003 May 27.

26.

Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function.

Salsi V, Caretti G, Wasner M, Reinhard W, Haugwitz U, Engeland K, Mantovani R.

J Biol Chem. 2003 Feb 28;278(9):6642-50. Epub 2002 Dec 12.

27.

Cloning and characterization of the histone-fold proteins YBL1 and YCL1.

Bolognese F, Imbriano C, Caretti G, Mantovani R.

Nucleic Acids Res. 2000 Oct 1;28(19):3830-8.

28.

Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter.

Caretti G, Cocchiarella F, Sidoli C, Villard J, Peretti M, Reith W, Mantovani R.

J Mol Biol. 2000 Sep 22;302(3):539-52.

PMID:
10986117
29.
30.

NF-Y associates with H3-H4 tetramers and octamers by multiple mechanisms.

Caretti G, Motta MC, Mantovani R.

Mol Cell Biol. 1999 Dec;19(12):8591-603.

31.

Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA.

Bonfanti M, La Valle E, Fernandez Sousa Faro JM, Faircloth G, Caretti G, Mantovani R, D'Incalci M.

Anticancer Drug Des. 1999 Jun;14(3):179-86.

PMID:
10500494
32.

In vivo analysis of the state of the human uPA enhancer following stimulation by TPA.

Ibañez-Tallon I, Caretti G, Blasi F, Crippa MP.

Oncogene. 1999 May 6;18(18):2836-45.

33.

Interactions of the CCAAT-binding trimer NF-Y with nucleosomes.

Motta MC, Caretti G, Badaracco GF, Mantovani R.

J Biol Chem. 1999 Jan 15;274(3):1326-33.

34.

[Irradiation of the internal mammary lymphatic chains in breast tumors. Insertion of a lenticular filter in conventional roentgenotherapy].

Cechetti E, Teofoli B, Putti C, Caretti G.

Radiobiol Radioter Fis Med. 1969 Jul-Aug;24(4):245-57. Italian. No abstract available.

PMID:
5400840
35.

[The use of a mechanical conformator in the radiotherapy of cavernous angiomas. (Technical note)].

Caretti G, Putti C, Teofoli B.

Radiobiol Radioter Fis Med. 1968 Nov-Dec;23(6):420-6. Italian. No abstract available.

PMID:
5747127
36.

[New model method with biplane negatoscopy for the mapping of anatomical parts and in particular for obstetrical cephalo-pelvimetry].

Caretti G, Golfieri G.

Radiol Med. 1966 Aug;52(8):771-96. Italian. No abstract available.

PMID:
5182443
37.

[Determination of contact dose in endocavitary therapy with cobalt 60 pearls and in interstitial therapy].

Caretti G, Chianura G.

Radiobiol Radioter Fis Med. 1965 Nov-Dec;20(6):476-88. Italian. No abstract available.

PMID:
5860896
38.
39.

[SCATTERED RADIATION IN DIAGNOSIS AND THERAPY AS RELATED TO THE PROFESSIONAL RISK].

CARETTI G, CHIANURA G.

Radiol Med. 1963 Aug;49:668-83. Italian. No abstract available.

PMID:
14055674
40.

[Technical and physico-dosimetric comparisons between a telecobaltotherapy unit and a Van de Braaff electrostatic generator].

MICELI R, CORINALDESI A, CARETTI G.

Radiobiol Radioter Fis Med. 1961 Jul;16:182-200. Italian. No abstract available.

PMID:
14473306
41.

[Apparatus for observation of the corporeal profiles].

MICELI R, CARETTI G.

Radiol Med. 1961 Mar;47:242-8. Italian. No abstract available.

PMID:
13770132

Supplemental Content

Loading ...
Support Center